Goldman Sachs Group Inc Codex Dna, Inc. Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$1.7 - $2.36 $17,392 - $24,145	-10,231 Reduced 38.17%	16,572 $28,000
Q3 2022 Nov 10, 2022	SELL	$1.7 - $2.36 $17,392 - $24,145	-10,231 Reduced 38.17%	16,572 $0
Q2 2022 May 14, 2024	BUY	$1.8 - $6.45 $48,245 - $172,879	26,803 New	26,803 $48,000
Q2 2022 Aug 15, 2022	SELL	$1.8 - $6.45 $229,924 - $823,897	-127,736 Reduced 82.66%	26,803 $48,000
Q1 2022 May 16, 2022	BUY	$4.12 - $10.36 $540,721 - $1.36 Million	131,243 Added 563.37%	154,539 $830,000
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $146,997 - $278,620	23,296 New	23,296 $252,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.